EUVIMEDEUVIMED entdecken
Open Access

Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology

Jacob S Hogan, John C Baumann, Neha Vapiwala, Jeff M Michalski, Benjamin W Fischer-Valuck, Patty Karraker, Minesh P Mehta, Jeffrey D Bradley, Brian C Baumann

Practical Radiation Oncology · 2026

DOI: 10.1016/j.prro.2025.05.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026. Verfasst von Jacob S Hogan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine in St. Louis, St. Louis, Missouri. Hauptthemen laut MEDLINE: Medicare, Radiation Oncology, Medical Oncology, Insurance, Health, Reimbursement. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Radiation and medical oncology face pressure from payment changes, which aim to increase the value of care and curb rising spending. Multiple models have been proposed or implemented, with mixed results for cost saving and financial stability. Whereas previous studies have quantified changes in Medicare reimbursement for radiation oncology on a per-code basis, this has not been done in medical oncology to our knowledge, and no direct comparisons have been made between oncology subspecialties at this level. Our study aims to quantify and analyze Medicare reimbursement changes for medical and radiation oncology billing codes. METHODS AND MATERIALS: In this longitudinal study of reimbursement, the publicly available Physician/Supplier Procedure Summary database was used to obtain Medicare reimbursement data for 2010, 2016, and 2020. All reimbursement for providers with primary provider codes 92 (radiation oncology), 83 (hematology oncology), and 90 (medical oncology) were analyzed, combining hematology and medical oncology. Inflation- and utilization-adjusted changes in reimbursement were calculated from 2010 to 2020 and 2016 to 2020 on a per-code basis with results grouped by specialty and billing category. RESULTS: From 2010 to 2020, inflation- and utilization-adjusted Medicare reimbursement decreased by $1.2 billion (-16%) for all codes, $705 million (-29%) for radiation oncology-specific codes, and $541 million (-10%) for medical oncology-specific codes. From 2016 to 2020, inflation- and utilization-adjusted reimbursement decreased by $299 million (-3%) for all codes, $108 million (-5.6%) for radiation oncology-specific codes, and $191 million (-2.2%) for medical oncology-specific codes. Chemotherapy (-40%) and radiation therapy (-33%) saw the largest decreases in inflation- and utilization-adjusted reimbursement from 2010 to 2020, whereas immunotherapy (+21%) saw the largest increase. CONCLUSIONS: Our analysis shows continually decreasing Medicare reimbursement for both radiation and medical oncology from 2010 to 2020 and 2016 to 2020. This decade-long continuous decline highlights the need for payment system stabilization-whether through episode-based payment models or another avenue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicareRadiation OncologyMedical OncologyInsurance, Health, ReimbursementReimbursement MechanismsUnited StatesHumansLongitudinal Studies

Autor:innen und Institutionen

  • Washington University School of Medicine in St. Louis, St. Louis, Missouri.
  • Princeton Radiation Oncology, Princeton, New Jersey.
  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Radiamind LLC, Denver, Colorado.
  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.

Förderung

  • NCI NIH HHS
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Hogan, J. S., Baumann, J. C., Vapiwala, N., Michalski, J. M., Fischer-Valuck, B. W., Karraker, P., Mehta, M. P., Bradley, J. D., & Baumann, B. C. (2026). Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2025.05.011

Vancouver

Hogan JS, Baumann JC, Vapiwala N, Michalski JM, Fischer-Valuck BW, Karraker P, et al. Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology. Practical Radiation Oncology. 2026. doi:10.1016/j.prro.2025.05.011

BibTeX
@article{Hogan2026,
  author = {Hogan, Jacob S and Baumann, John C and Vapiwala, Neha and Michalski, Jeff M and Fischer-Valuck, Benjamin W and Karraker, Patty and Mehta, Minesh P and Bradley, Jeffrey D and Baumann, Brian C},
  title = {Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology},
  journal = {Practical Radiation Oncology},
  year = {2026},
  doi = {10.1016/j.prro.2025.05.011}
}
Kostenlos starten →